As of 2025-12-18, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (97.01) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.95 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -473.8%.
The range of the Relative Valuation is (95.55) - (105.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 18.9x | 17.2x |
| Forward P/E multiples | 17.0x - 24.8x | 17.4x |
| Fair Price | (95.55) - (105.87) | (97.01) |
| Upside | -468.2% - -508.0% | -473.8% |
| Date | P/E |
| 2025-12-12 | -4.63 |
| 2025-12-11 | -4.64 |
| 2025-12-10 | -4.64 |
| 2025-12-09 | -4.62 |
| 2025-12-08 | -4.63 |
| 2025-12-05 | -4.64 |
| 2025-12-04 | -4.64 |
| 2025-12-03 | -4.64 |
| 2025-12-02 | -4.63 |
| 2025-12-01 | -4.62 |
| 2025-11-28 | -4.63 |
| 2025-11-26 | -4.63 |
| 2025-11-25 | -4.62 |
| 2025-11-24 | -4.59 |
| 2025-11-21 | -4.54 |
| 2025-11-20 | -4.52 |
| 2025-11-19 | -4.54 |
| 2025-11-18 | -4.53 |
| 2025-11-17 | -4.54 |
| 2025-11-14 | -4.56 |
| 2025-11-13 | -4.55 |
| 2025-11-12 | -4.59 |
| 2025-11-11 | -4.60 |
| 2025-11-10 | -4.59 |
| 2025-11-07 | -4.55 |
| 2025-11-06 | -4.56 |
| 2025-11-05 | -4.57 |
| 2025-11-04 | -4.56 |
| 2025-11-03 | -4.57 |
| 2025-10-31 | -4.58 |
| 2025-10-30 | -4.58 |
| 2025-10-29 | -4.59 |
| 2025-10-28 | -4.60 |
| 2025-10-27 | -4.61 |
| 2025-10-24 | -4.59 |
| 2025-10-23 | -4.58 |
| 2025-10-22 | -4.57 |
| 2025-10-21 | -4.58 |
| 2025-10-20 | -4.58 |
| 2025-10-17 | -4.57 |
| 2025-10-16 | -4.55 |
| 2025-10-15 | -4.57 |
| 2025-10-14 | -4.56 |
| 2025-10-13 | -4.55 |
| 2025-10-10 | -4.52 |
| 2025-10-09 | -4.55 |
| 2025-10-08 | -4.57 |
| 2025-10-07 | -4.58 |
| 2025-10-06 | -4.58 |
| 2025-10-03 | -4.58 |